Serrano CM, Tufet OJ

Language: Spanish
References: 11
Page: 233-239
PDF size: 334.41 Kb.

ABSTRACT

Background: hyperhidrosis and bromhidrosis are disorders related to excessive, generalized or local sweating, that can have a significant impact on the quality of life of patients who suffer from them. There are several treatments, both topical and invasive, with permanent or transitory effects. In recent years, microwave technology has been presented as a non-invasive procedure with permanent effects and few side effects. The objective of this study was to evaluate the efficacy, safety and degree of patient satisfaction, of the treatment of hyperhidrosis and axillary bromhidrosis by using microwave technology.
Material and Method: prior to the treatment, patients were diagnosed by the Hyperhidrosis Disease Severity Scale (hdss), the Minor test and they made a subjective assessment of their level of sweating. Subsequently they underwent a single microwave session and were followed for one, three, six and twelve months.
Results: throughout the follow-up period, an average of 49.88% of patients reported a subjective improvement of hyperhidrosis and 95% with respect to bromhidrois. The 80.40% of patients showed their satisfaction after comparing the results of their previous level of sweating and after one year of treatment. All side effects were resolved in a time not exceeding 10 weeks.
Conclusions: microwave technology proves to be an effective and lasting treatment in a single session for hyperhidrosis and/or axillary bromhidrosis.

REFERENCES

1. Atkins JL y Butler PEM, Hyperhidrosis: a review of current management, Plast Reconstr Surg 2002; 110(1):222-8.

2. Haider A y Solish N, Focal hyperhidrosis: diagnosis and management, cmaj 2005; 172(1):69-75.

3. Stolman LP, Hyperhidrosis: medical and surgical treatment, Eplasty 2008; 8:e22.

4. James AG, Austin CJ, Cox DS, Taylor D y Calvert R, Microbiological and biochemical origins of human axillary odour, fems Microbiol Ecol 2013; 83(3):527-40.

5. Strutton DR, Kowalski JW, Pharm D, Glaser DA y Stang PE, US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey, J Am Acad Dermatol 2004; 51(2):241-8.

6. Hasson A, Kam S y Cataldo K, Botulinum toxin in primary focal hyperhidrosis, Dermatología Rev Mex 2014; 58(4):331-8.

7. Jacob C, Treatment of hyperhidrosis with microwave technology, Semin Cutan Med Surg 2013; 32(1):2-8.

8. Hong HC, Lupin M y O’Shaughnessy KF, Clinical evaluation of a microwave device for treating axillary hyperhidrosis, Dermatol Surg 2012; 38(5):728-35.

9. Glaser DA, Coleman WP, Fan LK, Kaminer MS, Kilmer SL, Nossa R et al., A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration study, Dermatologic Surg 2012; 38(2):185-91.

10. Lupin M, Hong HC y O’Shaughnessy KF, Long-term efficacy and quality of life assessment for treatment of axillary hyperhidrosis with a microwave device, Dermatol Surg 2014; 40(7):805-7.

11. Sánchez-Carpintero I, Martín-Gorgojo A y Ruiz-Rodríguez R, Microwave treatment for axillary hyperhidrosis and bromhidrosis, Actas Dermosifiliogr 2017; 108(5):418-22.